Ablacon
Provider of AI-guided atrial fibrillation therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Jan 2021.)
Wheat Ridge Colorado (HQ)
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 1.4m | 2.3m | 2.9m | 2.9m | 2.9m |
% growth | - | 62 % | 26 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $2.0m | Series A | |
N/A | $30.0m | Series B | |
Total Funding | CAD43.6m |
Related Content
Recent News about Ablacon
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.